19th Annual Digestive Disease Week Review

Friday, May 29, 2026, 7:30 AM - 5:00 PM, Water's Edge Resort and Spa, Westbrook, CT


The Yale Digestive Disease Week Review, hosted by faculty from Yale School of Medicine, Department of Internal Medicine, Section of Digestive Diseases, is an annual continuing medical education program designed to deliver timely, clinically relevant updates from the national Digestive Disease Week (DDW) meeting. Each year, Yale faculty members attend DDW, identify the most impactful research, guideline updates, and therapeutic innovations, and then present these key learnings to regional gastroenterologists, hepatologists, primary-care clinicians, advanced practice providers, and other allied health professionals. This program ensures that clinicians who are unable to attend DDW receive a comprehensive and curated review of the newest advances in gastroenterology, hepatology, endoscopy, microbiome science, and digestive-disease management. The sessions emphasize translation of emerging evidence into daily clinical practice, promote interdisciplinary discussion, and support improved patient outcomes across the continuum of digestive health care.

1. Summarize the most important scientific updates, guideline changes, and emerging clinical evidence presented at the national Digestive Disease Week meeting.
2. Incorporate new diagnostic and therapeutic recommendations into clinical decision-making for common and complex GI and hepatology conditions.
3. Evaluate the implications of new endoscopic technologies, innovations, and procedural data for patient management and procedural planning.
4. Apply evidence-based strategies discussed at DDW to optimize patient outcomes in areas such as colorectal cancer screening, liver disease, IBD management, microbiome-related disorders, and gastrointestinal oncology.
5. Identify opportunities to reduce variation in clinical practice by aligning care with current national standards and expert-reviewed data.
6. Strengthen multidisciplinary collaboration by translating new research findings into coordinated care approaches across gastroenterology, hepatology, primary care, nutrition, and surgical specialties.
7. Enhance interprofessional collaboration by integrating DDW evidence and best practices into team-based approaches involving physicians, nurses, advanced practice providers, and other allied health professionals to improve communication, coordination, and overall quality of digestive health care.

Registration fee* includes continental breakfast, refreshment breaks, lunch and a reception:

• Physicians – $150
• Nurses/PAs/Allied Health Professionals – $75
• UCONN Faculty – $75
• CT SGNA Members – $50
• Non-Yale Residents/Fellows/Students† –$50
• Norwalk & Bridgeport Fellows – Complimentary, registration required
• Yale Residents/Fellows/Students† – Complimentary, registration required
• Yale Digestive Disease Faculty & Staff – Complimentary, registration required
• Yale Nurses – Complimentary, registration required

*All cancellations must be received in writing (or via e-mail) at least one week prior to the start of the conference to receive a refund. Any requests for refunds received after this date, or by telephone, will not be honored.

†A letter of verification from department head must accompany registration. Letter should be sent separately to Yale CME at the address below. You may also e-mail a pdf copy of your verification letter to [email protected]. 

If paying via check, include conference name in the memo, make check payable to Yale University and send to:

Center for Medical Education
c/o Farrah Nettleton
367 Cedar Street – ESH Building A – 2nd floor
New Haven, CT 06510

*Online registration will close the afternoon before the program. Onsite registrants accepted.

Accreditation Statement
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Designation Statement
The Yale School of Medicine designates this educational activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education (CME), to ensure balance, independence, objectivity, and scientific rigor in all its educational programs. All individuals involved in the development and presentation of Accredited Continuing Education activities are required to disclose all financial relationship(s) with ineligible companies (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients) that has occurred within the past 24 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. This information is disclosed to all activity participants prior to the commencement of the educational activity.

Mitigation of Financial Relationships Statement
Yale CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible companies. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Financial Statement
The Yale School of Medicine, Department of Internal Medicine, Section of Digestive Diseases is grateful to its supporters.  They are acknowledged in all conference materials.

AMA PRA Category 1 Credits™ (8.00 hours), Non-Physician Attendance (8.00 hours)

Mitigation of Relevant Financial Relationships

Yale Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, May 29, 2026

Register To Exhibit